Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_assertion type Assertion NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_head.
- NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_assertion description "[Comparison of mRNA from benign neuroblastic tumors and neuroblastomas revealed that expression of the type III TGF-? receptor (TGFBR3) decreases with advancing stage of neuroblastoma and this loss correlates with a poorer prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_provenance.
- NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_assertion evidence source_evidence_literature NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_provenance.
- NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_assertion SIO_000772 24216509 NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_provenance.
- NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_assertion wasDerivedFrom befree-20150227 NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_provenance.
- NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_assertion wasGeneratedBy ECO_0000203 NP734672.RAV29Va94NBXhZl9UVRowj62cwKewGFZM41M3kEwoIhKU130_provenance.